Detection of HER2-Low Lesions Using HER2-Targeted PET Imaging in Patients with Metastatic Breast Cancer: A Paired HER2 PET and Tumor Biopsy Analysis

医学 转移性乳腺癌 乳腺癌 活检 癌症 Pet成像 放射科 正电子发射断层摄影术 病理 核医学 内科学
作者
Randy Yeh,Fresia G. Pareja,Parnian Shobeiri,Dara S. Ross,Vetri Sudar Jayaprakasam,Ali Aria Razmaria,Joshua Z. Drago,Audrey Mauguen,Serge K. Lyashchenko,Brian M. Zeglis,Jason Stuart Lewis,Gary A. Ulaner
出处
期刊:Journal of nuclear medicine [Society of Nuclear Medicine and Molecular Imaging]
卷期号:66 (6): 873-879 被引量:13
标识
DOI:10.2967/jnumed.124.269227
摘要

Trastuzumab deruxtecan (T-DXd), a human epidermal growth factor receptor 2 (HER2)–targeted antibody–drug conjugate, demonstrated remarkable efficacy in previously treated patients with HER2-low metastatic breast cancer (mBC), marking a new therapeutic option for this patient population. Prior studies with HER2 PET using 89Zr-radiolabeled antibodies were limited by high rates of imaging false positives for HER2-positive malignancy. In this retrospective study, we investigate whether these false positives (HER2-negative on pathology) could be explained by HER2-low lesions. Methods: A retrospective study was conducted of mBC patients who previously enrolled in 2 prospective HER2 PET imaging trials: NCT02286843 using 89Zr-trastuzumab and 89Zr-pertuzumab and NCT04692831 using 89Zr-ss-pertuzumab. Patients were included if paired HER2 PET scan and biopsy were performed within a 2-mo period. Of 56 total patients, 23 patients met the inclusion criteria. Pathology results for biopsied lesions were collected, without repeat interpretation, and lesions were classified as HER2-positive, HER2-low, or HER2-0. SUVmax of biopsied lesions were compared between pathologic classifications to determine whether lesion uptake intensity could differentiate between HER2-positive and HER2-low lesions. Results: All prior false-positive lesions on HER2 PET scans from NCT02286843 were reclassified as HER2-low (instead of HER2-negative). In the 89Zr-trastuzumab cohort, 3 lesions were HER2-positive (33%) and 6 were HER2-low (67%); in the 89Zr-pertuzumab cohort, 2 were HER2-positive (29%) and 5 were HER2-low (71%). In the 89Zr-ss-pertuzumab cohort (NCT04692831), 7 patients underwent recent biopsies of 8 total lesions demonstrating 1 HER2-positive (12%), 5 HER2-low (62%), and 2 HER2-0 lesions (25%). HER2 PET SUVmax of biopsied lesions were compared between HER2-positive and HER2-low lesions for the combination of all 3 radiotracer cohorts. HER2-low lesions had a significantly higher SUVmax (median, 12.7; interquartile range, 8.05) than did HER2-positive lesions (median, 6.4; interquartile range, 1.98; P = 0.01). Conclusion: HER2 PET imaging with 89Zr-radiolabeled antibodies detects HER2-low lesions in addition to HER2-positive lesions in patients with mBC, suggesting its ability to visualize the entire spectrum of HER2 expression. All prior false positives on 89Zr-trastuzumab and 89Zr-pertuzumab PET scans were reclassified as HER2-low. Lesion SUVmax is not reliable in differentiating HER2-positive from HER2-low lesions; however, it may be useful in distinguishing lesions expressing HER2 from HER2-0 lesions.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zhang狗子完成签到,获得积分20
刚刚
Bagel完成签到 ,获得积分10
1秒前
笑哈哈完成签到,获得积分10
1秒前
1秒前
我爱科研发布了新的文献求助10
1秒前
1秒前
Baek完成签到,获得积分20
1秒前
上官若男的应助被xu采纳,获得10
2秒前
lllllling是玲玲呀完成签到,获得积分10
2秒前
零知识完成签到 ,获得积分10
3秒前
3秒前
ycp完成签到,获得积分0
3秒前
科目三的应助被hua采纳,获得10
3秒前
4秒前
Hello的应助被surain采纳,获得10
4秒前
大大大骁发布了新的文献求助10
4秒前
日月雨辰完成签到,获得积分10
5秒前
5秒前
5秒前
大模型的应助被zhang狗子采纳,获得10
5秒前
科研通AI2S的应助被Qawsed采纳,获得80
6秒前
6秒前
Elias完成签到,获得积分10
6秒前
无极微光的应助被雨小葵采纳,获得20
6秒前
fansofwhat完成签到,获得积分10
7秒前
聪慧夏之发布了新的文献求助10
7秒前
hfhkjh发布了新的文献求助10
7秒前
7秒前
Haonan完成签到,获得积分0
7秒前
情怀的应助被Charlie采纳,获得10
7秒前
DW的应助被一切顺利采纳,获得10
7秒前
7秒前
8秒前
8秒前
8秒前
sy111完成签到,获得积分10
8秒前
骆马湖完成签到,获得积分10
9秒前
赘婿的应助被龙行天下采纳,获得10
9秒前
9秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8176102
求助须知:如何正确求助?哪些是违规求助? 9567588
关于积分的说明 21793477
捐赠科研通 7770603
什么是DOI,文献DOI怎么找? 3431969
关于科研通互助平台的介绍 2556294
邀请新用户注册赠送积分活动 2477522